Healthcare sector | Medical Devices industry
| Price | $6.83 |
|---|---|
| Shares Outstanding | 27.15M |
| Net Current Assets / Share | $3.46 |
| Net Tangible Assets / Share | $5.69 |
| Max Earning Power / Share | $-0.67 |
| Adjusted Earning Power |
$-1.86
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
2.82%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Ave Max Earning Power (5Y) | $2.71 |
| Ave Max Earning Power (5Q Annualized) | $0.00 |
| Ave Max Earning Power Delta (5Q Ann - 5Y) | $-2.71 |
| Net Cash / Share | $0.31 |
| Dividend indicators | Value | Date |
|---|---|---|
| Pays Dividend | No | 12-19-2025 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 12-19-2025 |
| Net Income Positive | No | 12-19-2025 |
| Avg CA Burn (Annual %) | -22.28% | 12-19-2025 |
| Avg CA Burn (Quarterly %) | 1.31% | 12-19-2025 |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2025-11-10 | 27,148,482 | +108,092 |
| 2025-09-18 | 27,040,390 | -10 |
| 2025-08-12 | 27,040,400 | +153,200 |
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.